Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Current Oncology (Toronto, Ont.)|December 15, 2010
Screening for hepatitis B surface antigen before chemotherapy: current practice and opportunities for improvementR Lee, K Vu, C M Bell, et al.Journal of Viral Hepatitis|March 14, 2015
Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for lymphoma: a meta-analysisL Mozessohn, K K W Chan, J J Feld, et al.British Journal of Addiction|June 1, 1992
Eating disorders and alcohol abuse in womenD S Goldbloom, C A Naranjo, K E Bremner, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|October 18, 2016
Rituximab in Lymphoma and Chronic Lymphocytic Leukaemia: A Practice GuidelineA Prica, F Baldassarre, L K Hicks, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1995
Mouse VH7183 recombination signal sequences mediate recombination more frequently than those of VHJ558A M Connor, L J Fanning, J W Celler, et al.Advances in Hematology|December 23, 2011
HIV-Associated Burkitt Lymphoma: Good Efficacy and Tolerance of Intensive Chemotherapy Including CODOX-M/IVAC with or without Rituximab in the HAART EraJ A Rodrigo, L K Hicks, M C Cheung, et al.Bone Marrow Transplantation|November 26, 2008
Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphomaL K Hicks, A Woods, R Buckstein, et al.Annals of Hematology|January 9, 2015
Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximabN L Berinstein, S Bhella, N M Pennell, et al.Pageof 1